From: Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study
Demographic | Estrogen + P4 (N = 170) | P4 (N = 126) | P-value (Estrogen + P4 vs. P4) |
---|---|---|---|
Age (yrs); mean (SD) | 53 (7) | 50 (10) | <0.01 |
Weight (lbs); mean (SD) | 152 (32) | 155 (32) | 0.49 |
Comorbid Conditions; % | |||
Heart disease | 2 | 1 | 0.46 |
Dyslipidemia | 22 | 20 | 0.60 |
Hypertension | 9 | 17 | 0.04 |
Diabetes | 5 | 2 | 0.28 |
Cancer | 2 | 3 | 0.67 |
Thyroid | 14 | 13 | 0.72 |
Coagulopathies | 2 | 1 | 0.28 |
Hysterectomized; % | 38 | 27 | 0.02 |
Ovaries Removed; % | 32 | 21 | 0.04 |
Tobacco use; % | 8 | 9 | 0.95 |
Caffeine use; % | 70 | 79 | 0.18 |
Alcohol use; % | 54 | 52 | 0.51 |
Baseline CHT; % | 8 | 9 | 0.74 |
Baseline BHRT; % | 15 | 10 | 0.17 |